We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current RYTM market cap is 2.46B. The company's latest EPS is USD -3.0708 and P/E is -13.35.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 4.28M | 8.79M | 11.47M | 19.22M | 22.5M |
| Operating Income | -39.27M | -42.1M | -52.53M | -46.6M | -43.97M |
| Net Income | -40.86M | -42.49M | -52.18M | -46.7M | -44.16M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 3.15M | 23.64M | 77.43M |
| Operating Income | -146M | -136.58M | -170.06M | -179.16M | -184.36M |
| Net Income | -140.73M | -134M | -69.61M | -181.12M | -184.68M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 389.61M | 382.48M | 345.68M | 309.94M | 354.2M |
| Total Liabilities | 108.42M | 118.22M | 125.92M | 127.66M | 156.73M |
| Total Equity | 281.2M | 264.26M | 219.76M | 182.29M | 197.47M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 308.52M | 187.07M | 329.52M | 382.48M | 332.75M |
| Total Liabilities | 27.5M | 20.55M | 45.37M | 118.22M | 162.99M |
| Total Equity | 281.02M | 166.53M | 284.15M | 264.26M | 169.76M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -139.43M | -173.43M | -36.43M | -77.52M | -106.77M |
| Investing | 68.8M | 28.03M | 18.46M | 66.66M | -28.31M |
| Financing | 196.46M | 213.83M | -133k | -1.1M | 71.95M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -122.75M | -121.98M | -146M | -173.43M | -136.16M |
| Investing | -27.97M | 158.53M | -62.16M | 28.03M | -5.67M |
| Financing | 163.47M | 2.01M | 166.48M | 213.83M | 74.37M |
| Market Cap | 2.46B |
| Price to Earnings Ratio | -13.35 |
| Price to Sales Ratio | 31.85 |
| Price to Cash Ratio | 41.05 |
| Price to Book Ratio | 14.53 |
| Dividend Yield | - |
| Shares Outstanding | 60.14M |
| Average Volume (1 week) | 533.82k |
| Average Volume (1 Month) | 503.43k |
| 52 Week Change | 117.52% |
| 52 Week High | 52.57 |
| 52 Week Low | 15.5001 |
| Spread (Intraday) | 3.7 (8.47%) |
| Company Name | Rhythm Pharmaceuticals Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.rhythmtx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
